Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StePS pilot study of hydrocortisone in childhood severe sepsis
2007-002788-28Phase 2Terminated
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of hydrocortisone sodium succinate in sepsis (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoints: All-cause mortality at 28 days and Serious adverse events. Started Sep 2007; status: terminated.
02
Drugs
hydrocortisone sodium succinate
03
Conditions
sepsis
Beyond the preview
Go deeper on 2007-002788-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002788-28.